{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:40:19Z","timestamp":1762782019427,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.nwh.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T20:30:36Z","timestamp":1475699436000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause"],"prefix":"10.1016","volume":"20","author":[{"given":"Heidi Collins","family":"Fantasia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.nwh.2016.08.007_bb0005","first-page":"1139","article-title":"Prevention, recognition, and management of serotonin syndrome","volume":"81","author":"Ables","year":"2010","journal-title":"American Family Physician"},{"issue":"3","key":"10.1016\/j.nwh.2016.08.007_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1745-7599.2006.00206.x","article-title":"Treating vasomotor symptoms of menopause: The nurse practitioners perspective","volume":"19","author":"Alexander","year":"2007","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"issue":"4","key":"10.1016\/j.nwh.2016.08.007_bb0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.nwh.2016.08.007_bb0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carroll","year":"2015","journal-title":"International Journal of Women\u2019s Health"},{"issue":"2","key":"10.1016\/j.nwh.2016.08.007_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1552-6909.12282","article-title":"Hormone therapy for the management of menopause symptoms","volume":"43","author":"Fantasia","year":"2014","journal-title":"Journal of Obstetric, Gynecologic, & Neonatal Nursing"},{"issue":"2","key":"10.1016\/j.nwh.2016.08.007_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/1552-6909.12285","article-title":"Pharmacologic management of osteoporosis","volume":"43","author":"Fontenot","year":"2014","journal-title":"Journal of Obstetric, Gynecologic, & Neonatal Nursing"},{"issue":"3","key":"10.1016\/j.nwh.2016.08.007_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jcap.12046","article-title":"Psychopharmacology column: A review of psychotropic medication lactation risks for infants during breastfeeding","volume":"26","author":"Genung","year":"2013","journal-title":"Journal of Child and Adolescent Psychiatric Nursing"},{"issue":"1","key":"10.1016\/j.nwh.2016.08.007_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/2327-6924.12137","article-title":"The efficacy and tolerability of SSRI\/SNRIs in the treatment of vasomotor symptoms in menopausal women: A systematic review","volume":"27","author":"Handley","year":"2015","journal-title":"Journal of the American Association of Nurse Practitioners"},{"issue":"3","key":"10.1016\/j.nwh.2016.08.007_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv337","article-title":"Tamoxifen and antidepressant drug interaction in a cohort of 16,887 breast cancer survivors","volume":"108","author":"Haque","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"issue":"25","key":"10.1016\/j.nwh.2016.08.007_bb0050","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.nwh.2016.08.007_bb0055","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/AOG.0000000000001058","article-title":"Management of menopausal symptoms","volume":"126","author":"Kaunitz","year":"2015","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.nwh.2016.08.007_bb0060","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.nwh.2016.08.007_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.jp.7211352","article-title":"Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: A meta-analysis","volume":"25","author":"Lattimore","year":"2005","journal-title":"Journal of Perinatology"},{"year":"2014","series-title":"Highlights of prescribing information","author":"Noven Therapeutics","key":"10.1016\/j.nwh.2016.08.007_bb0070"},{"issue":"19","key":"10.1016\/j.nwh.2016.08.007_bb0075","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJMp1402080","article-title":"FDA approval of paroxetine for menopausal hot flushes","volume":"370","author":"Orleans","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.nwh.2016.08.007_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1755-5949.2010.00160.x","article-title":"Antide-pressant-induced suicidality: An update","volume":"16","author":"Reeves","year":"2010","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"10","key":"10.1016\/j.nwh.2016.08.007_bb0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":"Low-dose paroxetine 7.5mg for menopausal vasomotor symptoms: Two randomized controlled trials","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.nwh.2016.08.007_bb0090","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update","volume":"30","author":"Spina","year":"2008","journal-title":"Clinical Therapeutics"},{"issue":"23","key":"10.1016\/j.nwh.2016.08.007_bb0095","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/djg108","article-title":"Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotine reuptake inhibitor paroxetine","volume":"95","author":"Stearns","year":"2003","journal-title":"JNCI: Journal of the National Cancer Institute"},{"year":"2013","series-title":"FDA approves the first non-hormonal treatment for hot flashes associated with menopause [Press release]","author":"Food","key":"10.1016\/j.nwh.2016.08.007_bb0100"},{"year":"2011","series-title":"Osteoporosis: Screening","author":"U.S. Preventive Services Task Force","key":"10.1016\/j.nwh.2016.08.007_bb0105"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485116302161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485116302161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:41:43Z","timestamp":1761687703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485116302161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1751485116302161"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2016.08.007","relation":{},"ISSN":["1751-4851"],"issn-type":[{"type":"print","value":"1751-4851"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}